Patents by Inventor Beth A. Strifler

Beth A. Strifler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Muteins of fibroblast growth factor 21
    Publication number: 20070142278
    Abstract: The present invention relates to novel muteins of human fibroblast growth factor 21 with improved pharmaceutical properties. Both protein and the respective encoding nucleic acid species are disclosed. The invention also embodies vectors and host cells for the propagation of said nucleic acid sequences and the production of said muteins. Also disclosed are methods for treating type 2 diabetes, obesity, metabolic syndrome, and in reducing the mortality and morbidity of critically ill patients.
    Type: Application
    Filed: December 1, 2004
    Publication date: June 21, 2007
    Inventors: John Beals, Christopher Frye, Wolfgang Glaesner, Shun Li, Radhakrishnan Rathnachalam, Jing Shang, Beth Strifler, Radmila Micanovic
  • Human phospholipase A2 and related nucleic acid compounds
    Patent number: 6242206
    Abstract: The invention provides a novel phospholipase A2 enzyme, polynucleotides encoding such enzyme and methods for screening unknown compounds for anti-inflammatory activity mediated by the arachidonic acid cascade.
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: June 5, 2001
    Assignee: Eli Lilly and Company
    Inventors: Xue-Chiou C. Choiu, Ruth M. Kramer, Richard T. Pickard, John D. Sharp, Beth A. Strifler
  • Human phospholipase A2 and related nucleic acid compounds
    Patent number: 6197569
    Abstract: The invention provides a novel phospholipase A2 enzyme, polynucleotides encoding such enzyme and methods for screening unknown compounds for anti-inflammatory activity mediated by the arachidonic add cascade.
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: March 6, 2001
    Assignee: Eli Lilly and Company
    Inventors: Xue-Chiou C. Choiu, Ruth M. Kramer, Richard T. Pickard, John D. Sharp, Beth A. Strifler
  • Human phospholipase A.sub.2 and related nucleic acid compounds
    Patent number: 6025178
    Abstract: The invention provides a novel phospholipase A.sub.2 enzyme, polynucleotides encoding such enzyme and methods for screening unknown compounds for anti-inflammatory activity mediated by the arachidonic acid cascade.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: February 15, 2000
    Assignee: Eli Lilly and Company
    Inventors: Xue-Chiou C. Choiu, Ruth M. Kramer, Richard T. Pickard, John D. Sharp, Beth A. Strifler